Français
ItalianoBond GSK PLC 5.625% ( XS0335134705 ) in EUR
| Issuer | GSK PLC | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  United Kingdom
|
||||||
| ISIN code |
 XS0335134705 ( in EUR )
|
||||||
| Interest rate | 5.625% per year ( payment 1 time a year) | ||||||
| Maturity | 13/12/2017 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 50 000 EUR | ||||||
| Total amount | 1 250 000 000 EUR | ||||||
| Detailed description |
GSK PLC is a British multinational pharmaceutical and biopharmaceutical company headquartered in Brentford, UK, focused on research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products globally. A detailed analysis of the Euro-denominated bond identified by ISIN XS0335134705, issued by GSK PLC, a leading global pharmaceutical and biotechnology company headquartered in the United Kingdom, renowned for its extensive research, development, and manufacturing of innovative medicines, vaccines, and consumer healthcare products, reveals its key financial specifications and lifecycle progression; this bond, originating from the United Kingdom, carried a fixed annual interest rate of 5.625% on a total issuance size of 1,250,000,000 EUR, with a minimum purchase requirement of 50,000 EUR, and ultimately reached its scheduled maturity on December 13, 2017, at which point it was observed trading at 100% of its par value, signifying its complete repayment and successful redemption to bondholders. |
||||||
| |||||||